OverviewChartNewsTraderScreen

HSBC Put 3100 TDXP 18.12.2024/  DE000HS146Z0  /

EUWAX
11/10/2024  10:11:55 Chg.-0.060 Bid10:56:35 Ask10:56:35 Underlying Strike price Expiration date Option type
0.370EUR -13.95% 0.370
Bid Size: 10,000		 0.410
Ask Size: 10,000		 TECDAX 3,100.00 EUR 18/12/2024 Put
GlobeNewswire 22/07 MiddleGround Capital enters into Investment Agreement with STEMMER IMAGING AG and announces intentio...
GlobeNewswire 14/05 CENTOGENE and Evotec Discover Promising New Molecule to Treat Gaucher Disease
GlobeNewswire 12/06/2018 Software AG acquires Technology Scale-up TrendMiner for analysis and visualization of time series da...
GlobeNewswire 20/12/2016 Medigene announces outlicensing of AAVLP technology
GlobeNewswire 13/12/2016 MorphoSys Starts Phase 2 Trial of MOR208 in Combination with Idelalisib in Patients with Relapsed or...
GlobeNewswire 06/12/2016 Medigene AG to be included in TecDAX Index
GlobeNewswire 06/12/2016 MorphoSys Presents Updated Clinical Data for Blood Cancer Candidate MOR208 in NHL and CLL at ASH 201...
GlobeNewswire 06/12/2016 MorphoSys Presents Updated Clinical Results for Anti-CD38 Antibody MOR202 at ASH 2016
GlobeNewswire 28/11/2016 MorphoSys Announces That Its Licensee Janssen Has Submitted a Marketing Authorisation Application Fo...
GlobeNewswire 17/11/2016 MorphoSys Announces That Its Licensee Janssen Has Submitted Biologics License Application For Guselk...
GlobeNewswire 15/11/2016 MorphoSys Raises EUR 115 million in Private Placement
GlobeNewswire 15/11/2016 Ad hoc: MorphoSys Raises EUR 115 million in Private Placement
GlobeNewswire 15/11/2016 MorphoSys to Raise Capital via a Private Placement of New Shares
GlobeNewswire 15/11/2016 Ad hoc: MorphoSys to Raise Capital via a Private Placement of New Shares
GlobeNewswire 15/11/2016 MorphoSys Announces That Its Licensee Janssen Has Presented Positive Clinical Data of Guselkumab in ...
GlobeNewswire 14/11/2016 MorphoSys to Present at Upcoming Investor Conferences
GlobeNewswire 08/11/2016 Anke Linnartz joins MorphoSys as Head of Corporate Communications and Investor Relations
GlobeNewswire 07/11/2016 MorphoSys AG Reports Results for the First Nine Months of 2016
GlobeNewswire 03/11/2016 MorphoSys Announces Presentations of Clinical Data at Upcoming American Society of Hematology (ASH) ...
GlobeNewswire 02/11/2016 MorphoSys and LEO Pharma Enter into Strategic Alliance to Develop Therapeutic Antibodies in Dermatol...
GlobeNewswire 28/10/2016 MorphoSys to Host Q3 2016 Conference Call on November 7, 2016
GlobeNewswire 20/10/2016 MorphoSys Receives Clinical Milestone for Start of Phase 1 Trial with Novel Cancer Antibody
GlobeNewswire 17/10/2016 MorphoSys Presents Updated Clinical Results for MOR202 at Medical Conference
GlobeNewswire 01/10/2016 MorphoSys Announces That Its Licensee Janssen Reports Positive Results From A Phase 3 Study of Gusel...
GlobeNewswire 01/10/2016 Ad hoc: MorphoSys Announces That Its Licensee Janssen Reports Positive Results From A Phase 3 Study ...